Close Menu

clinical trial

NEW YORK (GenomeWeb News) – Illumina said today that it will partner with Global Genomics Group (G3) to provide whole-genome sequencing for the Genetic Loci and the Burden of Atherosclerotic Lesions, or GLOBAL, clinical trial.

A prospective study slated for publication has demonstrated that Precision Therapeutics' ChemoFx test was able to predict whether ovarian cancer patients would live longer if they took a particular chemotherapy.

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium has finished enrolling two studies investigating genetic markers linked to drug-induced liver injury and hypersensitivity reactions, and it has launched a new study focused on finding markers of treatment-related inf

Germany's Curetis said this week that it has begun an additional, prospective, multicenter clinical trial of its Unyvero P50 Pneumonia test to demonstrate its clinical and health economic value.

NEW YORK (GenomeWeb News) – The Oracle Health Sciences Network today announced the inclusion of Genetic Alliance into the network, creating a bridge "linking individuals in its crowd-sourced patient registry to clinical trials."

NEW YORK (GenomeWeb News) – VolitionRx today announced an agreement with Hvidovre Hospital, part of the University of Copenhagen in Denmark, covering two clinical trials for colorectal cancer.

NEW YORK (GenomeWeb News) – Myriad Genetics will conduct homologous recombination deficiency (HRD) testing on patients enrolled in PharmaMar's Phase II clinical study for its anti-tumor drug candidate under a deal announced after the close of the market on Tuesday.

NEW YORK (GenomeWeb News) – PrimeraDx today announced a deal with Quest Diagnostics to co-develop molecular diagnostic products and services.
The focus of the non-exclusive deal is to support drug developers in the clinical development of targeted therapeutics.

NEW YORK (GenomeWeb News) – Veridex announced this week a deal with Laboratory Corporation of America to make its CellSearch circulating tumor cell test available in China.

Though not defined by any one major breakthrough as in years past, the RNAi therapeutics field made steady progress in 2012, particularly in terms of product and technology development, according to industry insiders.

Pages

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.